RxDoctor Payments Data

Jorge Gilbert, MD

Gastroenterology · Sioux Falls, SDNPI 1205831377

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Aimmune Therapeutics, Inc. at 45.1% of the total.

$2,126in general payments, 2019–2025

Across 36 payments — averaging $59.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aimmune Therapeutics, Inc.$958
  • Sanofi$484
  • Ferring Pharmaceuticals Inc.$124
  • Regeneron Healthcare Solutions, Inc.$123
  • Takeda Pharmaceuticals U.S.A., Inc.$84
  • AbbVie$83
  • plus $269 from 6 others

What the payments were for

  • Food & beverage$2,11099%
  • Education$161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,126 in reported general payments places this provider in the 55th percentile of 41 gastroenterology providers in South Dakota.

See all gastroenterology providers in South Dakota

Medicare billing

Part B allowed, 2024
$86,147
Medicare patients
428
Services billed
628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira PenAdalimumab13$85,627
Humira(Cf) PenAdalimumab12$80,995
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates337$23,428
Mesalamine55$19,420
Dexlansoprazole DrDexlansoprazole13$4,339
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg148$4,173
Omeprazole129$1,387
CholestyramineCholestyramine (With Sugar)18$1,263
Azathioprine19$1,057
Balsalazide Disodium12$1,003
Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg29$502
Ondansetron Hcl431$341
Pantoprazole Sodium15$245

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →